Cargando…

Computational polypharmacology comes of age

Detalles Bibliográficos
Autores principales:	Rastelli, Giulio, Pinzi, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516879/ https://www.ncbi.nlm.nih.gov/pubmed/26283966 http://dx.doi.org/10.3389/fphar.2015.00157

Ejemplares similares

Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
por: Pinzi, Luca, et al.
Publicado: (2021)

Trends and Applications in Computationally Driven Drug Repurposing
por: Pinzi, Luca, et al.
Publicado: (2023)

Polypharmacology of Berberine Based on Multi-Target Binding Motifs
por: Chu, Ming, et al.
Publicado: (2018)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)

Advances in Computational Polypharmacology
por: Feldmann, Christian, et al.
Publicado: (2022)

Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing
por: Bernal, Leonardo, et al.
Publicado: (2023)

Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets
por: Saqib, Uzma, et al.
Publicado: (2018)

Refinement and Rescoring of Virtual Screening Results
por: Rastelli, Giulio, et al.
Publicado: (2019)

Molecular Docking: Shifting Paradigms in Drug Discovery
por: Pinzi, Luca, et al.
Publicado: (2019)

Chemogenomics knowledgebased polypharmacology analyses of drug abuse related G-protein coupled receptors and their ligands
por: Xie, Xiang-Qun, et al.
Publicado: (2014)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Molecular Connectivity Predefines Polypharmacology: Aliphatic Rings, Chirality, and sp(3) Centers Enhance Target Selectivity
por: Monteleone, Stefania, et al.
Publicado: (2017)

Prediction of activity and selectivity profiles of human Carbonic Anhydrase inhibitors using machine learning classification models
por: Tinivella, Annachiara, et al.
Publicado: (2021)

Chemoinformatics Analyses of Tau Ligands Reveal Key Molecular Requirements for the Identification of Potential Drug Candidates against Tauopathies
por: Pinzi, Luca, et al.
Publicado: (2021)

Development of machine learning classifiers to predict compound activity on prostate cancer cell lines
por: Bonanni, Davide, et al.
Publicado: (2022)

Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies
por: Nikolic, Katarina, et al.
Publicado: (2016)

The Polypharmacological Effects of Cannabidiol
por: Castillo-Arellano, Jorge, et al.
Publicado: (2023)

Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90
por: Pinzi, Luca, et al.
Publicado: (2020)

CaMKII comes of age in cardiac health and disease
por: Grandi, Eleonora, et al.
Publicado: (2014)

Repositioning Natural Products in Drug Discovery
por: Rastelli, Giulio, et al.
Publicado: (2020)

LigAdvisor: a versatile and user-friendly web-platform for drug design
por: Pinzi, Luca, et al.
Publicado: (2021)

Structural and Functional View of Polypharmacology
por: Moya-García, Aurelio, et al.
Publicado: (2017)

In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA)
por: Pinzi, Luca, et al.
Publicado: (2019)

Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications
por: Citarella, Andrea, et al.
Publicado: (2021)

Design and Synthesis of Hsp90 Inhibitors with B‐Raf and PDHK1 Multi‐Target Activity
por: Pinzi, Luca, et al.
Publicado: (2021)

Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies
por: Tinivella, Annachiara, et al.
Publicado: (2022)

Automated design of ligands to polypharmacological profiles
por: Besnard, Jérémy, et al.
Publicado: (2012)

Exploiting kinase polypharmacology for nerve regeneration
por: Al-Ali, Hassan, et al.
Publicado: (2016)

How polypharmacologic is each chemogenomics library?
por: Ni, Eric, et al.
Publicado: (2020)

Polypharmacology of ambroxol in the treatment of COVID-19
por: Wang, Ziyuan, et al.
Publicado: (2023)

Polypharmacology: promises and new drugs in 2022
por: Ryszkiewicz, Piotr, et al.
Publicado: (2023)

Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status
por: Pinzi, Luca, et al.
Publicado: (2023)

Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR
por: Foschi, Francesca, et al.
Publicado: (2022)

The Mycobacterium tuberculosis Drugome and Its Polypharmacological Implications
por: Kinnings, Sarah L., et al.
Publicado: (2010)

Curation and Analysis of Multitargeting Agents for Polypharmacological Modeling
por: Reddy, A. Srinivas, et al.
Publicado: (2014)

The kinase polypharmacology landscape of clinical PARP inhibitors
por: Antolin, Albert A., et al.
Publicado: (2020)

In silico polypharmacology: retrospective recognition vs. rational design
por: Proschak, Ewgenij
Publicado: (2014)

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
por: Ciceri, Pietro, et al.
Publicado: (2014)

Epigenetic polypharmacology: from combination therapy to multitargeted drugs
por: de Lera, Angel R., et al.
Publicado: (2016)

Privileged Structures and Polypharmacology within and between Protein Families
por: Meyers, Joshua, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j5b2mrrk865374vnr1id34rlho